Eurofins Scientific (Luxembourg), an international group of laboratories, has plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland.
Eurofins Livingston facility
Eurofins Scientific (Luxembourg), an international group of laboratories, has plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland, as part of a £4 million investment.
The 5800-square meter facility at Brucefield Industry Park will house Eurofin’s biopharmaceutical testing business in the UK, currently based in Edinburgh. The first phase of the project will include the development of 1400 square meters of laboratory space.
As part of the investment, Eurofins BioPharma Product Testing UK will be purchasing a new inductively coupled plasma-mass spectrometry (ICP-MS) instrument, allowing the company to meet growing demand for this service as a result of new International Conference Harmonization (ICH) guidelines and pharmacopeial chapters on testing drugs for elemental impurities. Eurofins will also invest in more high-performance liquid chromatography (HPLC) equipment, increasing that capacity by 40%.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.